No Prescription |
 |
 | ||
|
Dutin Cymbalta |
|
| ||
No Prescription » Prescription Drugs 6 » Dutin Cymbalta Duloxetine (du-LOX-uh-teen) is used to treat mental depression. It is also used for pain caused by nerve damage associated with diabetes.Duloxetine belongs to a group of medicines known as selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). These medicines are thought to work by increasing the activity of chemicals called serotonin and norepinephrine in the brain.Duloxetine is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). Duloxetine affects chemicals in the brain that may become unbalanced and cause depression.Duloxetine is used to treat major depressive disorder and general anxiety disorder. It is also used to treat pain caused by nerve damage in people with diabetes (diabetic neuropathy).Duloxetine is used to treat major depression--a disorder marked by continuing serious and overwhelming feelings of depression that interfere with daily functioning. Symptoms may include major changes in appetite or sleep habits; lack of interest in social or work life; feelings of sadness guilt or worthlessness; fatigue; difficulty concentrating or making decisions; and suicidal thoughts or attempted suicide.Duloxetine is also used to treat diabetic peripheral neuropathy a painful nerve disorder associated with diabetes that affects the hands legs and feet.Duloxetine is thought to work by correcting an imbalance of two brain chemicals known to influence mood--serotonin and norepinephrine. It belongs to a class of antidepressants called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). Buy Dutin Cymbalta and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Dutin Cymbalta: Product Type: Prescription Drugs 6 Dutin ( Cymbalta Generic Duloxetine ) Dutin (Cymbalta Generic Duloxetine) Cymbalta Generic Duloxetine 30mg 3 Boxes ( 300 Caps ) Box ( 100 Caps ) Cymbalta Generic Duloxetine Dutin
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
